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Research
Transcription factor redundancy and tissue-specific
regulation: Evidence from functional and physical
network connectivity
Steven G. Kuntz,1 Brian A. Williams,1 Paul W. Sternberg,1,2,3 and Barbara J. Wold1,3
1Division of Biology, 2Howard Hughes Medical Institute, California Institute of Technology, Pasadena, California 91125, USA
Two major transcriptional regulators of Caenorhabditis elegans bodywall muscle (BWM) differentiation, hlh-1 and unc-120, are
expressed in muscle where they are known to bind and regulate several well-studied muscle-specific genes. Simultaneously
mutating both factors profoundly inhibits formation of contractile BWM. These observations were consistent with a simple
network model in which the muscle regulatory factors drive tissue-specific transcription by binding selectively near
muscle-specific targets to activate them. We tested this model by measuring the number, identity, and tissue-specificity of
functional regulatory targets for each factor. Some joint regulatory targets (218) are BWM-specific and enriched for
nearby HLH-1 binding. However, contrary to the simple model, the majority of genes regulated by one or both muscle
factors are also expressed significantly in non-BWM tissues. We also mapped global factor occupancy by HLH-1, and
created a genetic interaction map that identifies hlh-1 collaborating transcription factors. HLH-1 binding did not predict
proximate regulatory action overall, despite enrichment for binding among BWM-specific positive regulatory targets of
hlh-1. We conclude that these tissue-specific factors contribute much more broadly to the transcriptional output of muscle
tissue than previously thought, offering a partial explanation for widespread HLH-1 occupancy. We also identify a novel
regulatory connection between the BWM-specific hlh-1 network and the hlh-8/twist nonstriated muscle network. Finally,
our results suggest a molecular basis for synthetic lethality in which hlh-1 and unc-120 mutant phenotypes are mutually
buffered by joint additive regulation of essential target genes, with additional buffering suggested via newly identified hlh-1
interacting factors.
[Supplemental material is available for this article.]
Gene networks that govern cell-type-specificity typically center
around a few core transcription factors that interact directly, both
physically and genetically, with ‘‘terminal differentiation’’ regula-
tory target genes (Davidson 2007). For the muscle gene network,
these core factors are evolutionarily conserved in vertebrates and
invertebrates, consisting of bHLH factors of the MyoD family and
members of the MADS family (Fukushige et al. 2006). Decades of
detailed genetic and molecular studies of selected ‘‘model’’ muscle
genes showed that core factors interact physically and functionally
with their transcriptional enhancers and promoters. This led to
a parsimonious working model in which core factor occupancy
specified all muscle-restricted transcription and thus defined the
terminal differentiation state. It is now possible to test this and to
probe more deeply how the core regulators act individually, addi-
tively, and/or synergistically on their targets. In principle, it is
straightforward to build and compare a global physical map of
factor occupancy determined by ChIP-seq (Johnson et al. 2007)
with a corresponding perturbation map of factor function whose
global output is measured by mRNA-seq (Mortazavi et al. 2008).
Many differentiation systems now have good genomic maps of
one kind but not the other due to various technical and biological
limitations, but Caenorhabditis elegans bodywall muscle (BWM) is
especially amenable to both kinds of mapping. In particular, its
core BWM transcription factors, hlh-1 and unc-120, comprise
a synthetic embryonic lethal pair. This permits each factor to be
eliminated individually and the regulatory impact measured in
muscle tissue, thus avoiding the problems of other systems in
which mutation of a single factor eliminates the tissue entirely.
This comparison can also address questions emerging from related
systems, including mammalian myogenesis (Cao et al. 2010), in
which factor occupancy maps are revealing much more pervasive
physical occupancy across the genome thanwas initially expected.
Nematodes have three distinct muscle regulatory networks
that establish and maintain the differentiated states for their re-
spective tissues: bodywall muscle, nonstriatedmuscles (NSM), and
pharyngeal muscle (PhM). Each core network has a dedicated
transcription factor (hlh-1 in BWM, hlh-8 in NSM, ceh-22 in PhM)
(Fig. 1A; Chen et al. 1992, 1994; Williams and Waterston 1994;
Fukushige et al. 2006; Lei et al. 2009). These dedicated factors are
joined by semidedicated factors expressed inmultiplemuscle types
and muscle-associated cells (muscle-associated GLR cells, coelo-
mocytes, and the contractile somatic gonad) but not in other tis-
sues (unc-120 in both NSM and BWM) (Baugh et al. 2005a;
Fukushige et al. 2006), and they are joined by more general factors
that act in both nonmuscle and muscle tissues.
BWM is functionally analogous to the skeletal muscle of
vertebrates and insects (Albertson and Thomson 1976; Chen et al.
1994; Fukushige et al. 2006), being the most prominent muscle in
the animal by cell number and mass (81 embryonic and 14 post-
embryonic BWM cells) (Sulston and Horvitz 1977; Sulston et al.
1983). Five transcription factors are known to regulate BWM: hlh-1,
unc-120, hnd-1, ceh-51, and fozi-1 (Fig. 1A; Harfe et al. 1998a;Mathies
et al. 2003; Fukushige et al. 2006; Amin et al. 2007; Broitman-Maduro
et al. 2009). Ectopic expression of some can convert early blastomeres
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to muscle, based on myosin reporter assays, and hlh-1 is the most
efficient, with all five up-regulating endogenous hlh-1 and unc-120
(Fukushige and Krause 2005; Fukushige et al. 2006; Broitman-
Maduro et al. 2009). unc-120 is the most critical hlh-1 collaborator,
based on its synthetic lethality with hlh-1 (Baugh et al. 2005b) and
its expression throughout BWM (Baugh et al. 2005a; Fukushige
et al. 2006). In contrast, the other factors are confined to devel-
opmentally early times of specification or very early differentiation
and are restricted to subsets of BWM or are not specific to muscle
(Baugh et al. 2003; Amin et al. 2007; Yanai et al. 2008; Broitman-
Maduro et al. 2009). For these reasons, we consider hlh-1 and unc-120
to be the core regulators for the differentiated BWM network.
Detailed knowledge of connectivity between hlh-1 or unc-120
and their downstream targets comes from studies of specific target
genes, myo-3, unc-54, and pat-3, where binding of the factor was
observed at a specific (mutable and essential) cis-regulatorymodule
(CRM) (Francis andWaterston 1985; Fukushige et al. 2006; Lei et al.
2009). These targets and their CRMs serve as internal standards
for genomic assays in this work. Whether specific binding and
action of HLH-1 and/or UNC-120 proteins regulates the hundreds
of additional BWM genes has been untested, and the extent of
individual versus shared connectivity is unknown. Recent studies
that mapped HLH-1 protein occupancy across the entire genome
(Gerstein et al. 2010; Lei et al. 2010)
showed widespread binding with prox-
imity to both muscle-specific and non-
muscle genes, but those studies did not
directly address the relationship be-
tween binding and genome-wide regu-
latory dependence on the transcription
factors.
Nonstriated muscles comprise a mi-
nor fraction of C. elegans (four embry-
onic, 16 post-embryonicmuscles, and 10
contractile somatic gonad sheath cells)
(Sulston and Horvitz 1977; Sulston et al.
1983). NSM uses hlh-8 as its major tran-
scriptional regulator (Harfe et al. 1998b;
Corsi et al. 2000; Liu and Fire 2000)
along with unc-120 (Fukushige et al.
2006) and, in a subset of the NSM, mls-1
(Kostas and Fire 2002; Reece-Hoyes et al.
2007). Ectopic hlh-8 produces NSM phe-
notypes in other cell types (Harfe et al.
1998b;Wang et al. 2006; Zhao et al. 2007).
hlh-8 and hlh-1 are transiently coexpressed
in the post-embryonic M cell, whose
progeny ultimately include 14 BWM cells
expressing only HLH-1, 16 NSM cells
expressing only hlh-8, and twononmuscle
coelomocytes (Sulston and Horvitz 1977).
Themolecular and regulatory relationship
of BWM and NSM networks is a second
focus of this work, based on our findings
of crosstalk between them.
Here, we construct a C. elegans
BWM genomic resource consisting of
RNA-seq transcriptomes of the wild-
type, hlh-1 mutant, and unc-120 mutant
BWM plus ChIP-seq HLH-1 factor occu-
pancy. Cell type classifications (BWM,
general, or non-BWM) are assigned to
regulatory target genes by comparing transcriptome measure-
ments from BWM-enriched embryos and normal embryos. We
then dissect unique and shared regulatory contributions from
each factor by comparing transcriptomes of wild-type embryos
with those of hlh-1 mutant and unc-120 mutant embryos. This
reveals the regulatory influence of each factor on muscle-specific
versus broadly expressed genes. We also provide a genetic re-
source of previously unknown hlh-1 interacting factors identified
via a synthetic RNAi screen. Finally, we measure the number, lo-
cation, and DNA sequence motif composition of in vivo HLH-1
bound regions to evaluate how biochemical factor binding is re-
lated to regulatory impact (Fig. 1B).
Prior genetic studies showed that no single factor in the
core BWMnetwork is essential for muscle differentiation (Baugh
et al. 2005b; Fukushige et al. 2006; Broitman-Maduro et al. 2009),
suggesting there is partial ‘‘redundancy’’ between factors, although
no specific molecular explanation was suggested. Among genes
affected by hlh-1 mutation in our study, one coherent set of
transcription factors includes hlh-8/twist, which is known to
positively regulate NSM differentiation. We discuss how this
finding, plus other properties of the hlh-1/unc-120 network,
contributes to the tolerance of worm BWM myogenesis to hlh-1
and unc-120 mutation.
Figure 1. Experimental flow and muscle differentiation network. (A) The three types of nematode
muscle and their associated transcription factors. (B) The experiments performed across three RNAi
conditions (mex-3; skn-1; elt-1 RNAi,mex-3 RNAi, and no RNAi) in N2, hlh-1(cc561), and unc-120(st364).
(C ) The embryonic development lineageswith BWMcell number in normal embryos (red) are highlighted
to show which lineages are enhanced under the RNAi conditions (mex-3 RNAi and mex-3; skn-1; elt-1
RNAi).
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Results
Increasing muscle by respecification
reduces nonmuscle background
Our overall study design for genomic
measurements is shown in Figure 1B. We
increased BWM in embryos by knocking
down known specification genes for non-
BWM lineages that act prior to hlh-1 and
unc-120 (Fig. 1C). Only one-sixth of C.
elegans normally becomes bodywall
muscle (Sulston et al. 1983). This presents
signal-to-noise problems for ChIP and
transcriptome experiments by diluting
signal and obscuring any signal’s cell type
source. Increasing the proportion of
BWM can ameliorate these problems, but
prior methods (Bowerman et al. 1992;
Draper et al. 1996; Page et al. 1997; Baugh
et al. 2005a) had specific disadvantages
for our purposes (Methods).We increased
muscle content without directly aug-
menting the muscle network itself by
respecifying nonmuscle fates to a muscle
fate. RNAi knockdown of mex-3 can
double muscle (Draper et al. 1996), while
joint knockdown ofmex-3, skn-1, and elt-1
is expected to convert over 80% of cells
to BWM. mex-3 acts three cell divisions
before HLH-1 expression (Draper et al.
1996; Hunter and Kenyon 1996), skn-1
acts two or three cell divisions beforehand
(Bowerman et al. 1992; Blackwell et al.
1994), and elt-1 acts around the time hlh-1
will be activated (Spieth et al. 1991; Page
et al. 1997; Michaux et al. 2001) but still
permits hlh-1 expression.
We assayed three conditions: no RNAi
(empty vector);mex-3 RNAi only; and elt-1,
mex-3, and skn-1 triple RNAi. Since knock-
ing down multiple genes via RNAi can
significantly reduce the efficiency of each
individual knockdown (Gonczy et al. 2000;
Gouda et al. 2010), we concatenated RNAi
coding sequences to produce a single
transcript. As expected, muscle-specific
transcripts such as tnt-2 and tnt-3 were
enriched by the RNAi strategy across two
biological replicates (Fig. 2A). Known
nonmuscle genes, such as tnc-2, were re-
duced with RNAi (Fig. 2B). Genes broadly
expressed in both BWM and non-BWM,
such as pat-10, were not significantly af-
fected by RNAi (Fig. 2C). Muscle from the
triple RNAi sample, unlike mex-3 alone,
should be dominated by the C and D line-
ages, at the expense of theMS lineage. The
mex-3 RNAi condition,which doubles the
BWM contribution compared with wild
type, is included to retain MS-derived
muscle for observation (Figs. 1C, 2F).
Figure 2. Mutation and RNAi-based muscle enrichment impact gene expression levels. (A) Muscle
troponin T tnt-3 exemplifies genes enriched in muscle-enhanced embryos (red). Muscle-normal
expression (black) is nonzero since these animals retain significant muscle. (B) Non-BWM troponin C
tnc-2 exemplifies genes depleted in muscle-enriched embryos. BWM-enriched animals (red) have
reduced non-BWM tissue, so little expression is seen. (C ) Troponin pat-10, which is expressed in both
BWM and non-BWM, exhibits a negligible net change. (D) dhp-2 (dihydropyrimidinase) and (E ) lbp-3
(lipid-binding) are both muscle-enriched. dhp-2 is affected by hlh-1 loss of function, and lbp-3 is
affected by unc-120 loss-of-function, suggesting positive regulation by the BWM transcription fac-
tors. (F ) Group averages of the ratiometric change for the muscle-enriched genes (those significantly
up-regulated in muscle-enriched animals), nonmuscle-enriched (those significantly down-regulated
in muscle-enriched animals) genes, and annotated BWM genes (which significantly overlap with
NSM and PhM genes and are, therefore, more broadly expressed) are plotted against the RNAi
feeding conditions. (G) Overlap of hlh-1 and unc-120 regulated genes, both positively and negatively
regulated, including the 441 genes positively regulated by both unc-120 and hlh-1. The number of
genes in the other intersects are listed. (H) BWM transcription factors regulate more broadly
expressed RNAs than BWM-specific ones. A total of 1139 genes whose RNA levels are significantly
regulated by hlh-1 and/or unc-120 are expressed exclusively in BWM; hlh-1 and unc-120 significantly
regulated 1068 and 2694 broadly expressed genes. (RPKM) Reads per kilobase of gene structure
model per million reads.
hlh-1 and unc-120 network in worm myogenesis
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RNA-seq reveals hlh-1 and unc-120 regulatory targets, many
of which are shared
We quantified transcriptomes from total polyA+ RNA using RNA-
seq (Mortazavi et al. 2008). The ;400-min developmental time
point (twofold through threefold stage at 25°C in wild-type ani-
mals) was used to ensure that BWMcells had already been specified,
thus capturing embryos during differentiation. Due to concerns
over variations in timing across mutants and RNAi conditions, we
verified that both hnd-1 and ceh-51 had shut down in all animals
(RPKM < 2), indicating that our samples across replicates and con-
ditions represent middle to late differentiation. To identify regula-
tory targets of hlh-1 and unc-120, we compared wild type and tem-
perature-sensitivehlh-1(cc561) and unc-120(st364)mutants cultured
at the nonpermissive temperature, both with and without RNAi
feeding. When the hlh-1(cc561) parent generations are elevated to
the nonpermissive temperature prior to egg fertilization at the L4
stage, no detectable HLH-1 remains in the resulting embryos, and
there is no maternal or zygotic effect (Chen et al. 1994), as con-
firmed here by immunoprecipitation (Methods).
We defined hlh-1 and unc-120 regulatory targets as genes whose
expression differs significantly (average expression 6 one standard
deviation) between wild-type embryos and the mutant hlh-1(cc561)
or unc-120(st364) under RNAi-treated conditions (mex-3 and mex-3;
elt-1; skn-1 triple RNAi) (Fig. 1B). Among 13,216 genes expressed
above background, 1445 are hlh-1 regulatory targets by these rela-
tively conservative criteria, andwe expect them to include bothdirect
and indirect mechanisms (Table 1). Of these, 837 decreased signifi-
cantly (one standard deviation) in the mutant, consistent with a
simple positive mechanism of action for HLH-1 (Lei et al. 2009;
see Discussion). Conversely, 608 genes were up-regulated by loss of
HLH-1. These are explained most simply by indirect negative mech-
anisms, although the mammalian hlh-1 ortholog, MyoD, can act as a
direct negative factor at a few target genes (Berkes et al. 2004;Dilworth
et al. 2004; Penn et al. 2004). Mutation of unc-120 significantly re-
duced RNA levels from 2718 genes in muscle-enhanced embryos
(Table 1), while 956 genes had significantly higher transcript levels.
Among 592 transcription factor genes detectably expressed in
our samples, 22 were up-regulated and 12 down-regulated in hlh-1
mutant embryos, while 13 were up-regulated and 103 down-
regulated in unc-120 mutants (Supplemental Table S1). tbp-1 and
nhr-63, regulated by hlh-1, also interact with hlh-1 in an RNAi
synthetic lethal screen (see below), making them especially strong
candidatemembers of amore complete BWMtranscriptionnetwork
(Discussion). hlh-1 has a proportionally more negative effect than
unc-120 on transcription factors, which may reflect their differing
roles in BWMandNSM. A specific and unexpected example of hlh-1
negative regulation was hlh-8. Because hlh-8 is the major positive
transcriptional regulator of NSM (Corsi et al. 2000, 2002; Liu and
Fire 2000), this observation suggests a previously unknown regula-
tory connection between the BWM and NSM networks. In the unc-
120mutants, the transcript level of unc-120 itself was up-regulated,
suggesting that there is a negative autoregulatory feedback loop.
unc-120was not, however, significantly affected by hlh-1mutation.
This result differs from a prior report of unc-120 regulation by hlh-1
(Yanai et al. 2008), although that study was performed at earlier
developmental time-points during specification andused a different
significance criteria and measurement technology (RT-PCR).
Seven hundred and sixty genes were significantly regulated
by both unc-120 and hlh-1 (P < 0.001 for joint regulation), thus
offering an explanation for these genes’ continued though di-
minished expression when either factor is mutated. Four hundred
and forty-one of these genes were positively regulated by both
factors and 144 were jointly negatively regulated (Table 1; Fig. 2G).
An additional 175 genes were divergently regulated between the
two factors. The negative and mixed groups include genes best
explained by differential regulation between BWM and NSM reg-
ulatory networks (Discussion).
hlh-1 and unc-120 regulate many BWM and non-BWM
muscle genes
We next asked how hlh-1 and unc-120 regulatory target status is
parsed among genes expressed preferentially in BWM, genes
expressed in both BWM and other tissues, and genes expressed
exclusively elsewhere. The last group serves as ameasure of noncell
autonomous effects and background. Bodywall muscle-enriched
geneswere defined by comparing RNA-seq of N2 control (no RNAi)
embryos with RNAi-treatedmuscle-enriched animals. Overall, 2058
genes had expression levels significantly higher (one standard de-
viation) in BWM-enriched worms than in control, including many
classical markers of BWM (Supplemental Table S2). From a pre-
viously described set ofmuscle structural genes (Fox et al. 2008), our
set included 20 of their 38 genes, with the discordant 18 being
Table 1. Impact of hlh-1 mutation on expression levels in BWM-enriched worms
Regulation Muscle-specifica Widespreadb
Low in
musclec
Absent in
muscled Total
hlh-1 and unc-120 positively regulated 126 195 120 0 441
unc-120 only positively regulated 667 1157 358 0 2182
hlh-1 only positively regulated 66 151 99 0 316
Expressed but unchanged 919 3839 814 1157 6729
hlh-1 only negatively regulated 93 183 43 50 369
unc-120 only negatively regulated 95 470 130 37 732
hlh-1 and unc-120 negatively regulated 38 71 28 7 144
hlh-1 positively regulated and unc-120 negatively regulated 20 25 35 0 80
unc-120 positively regulated and hlh-1 negatively regulated 34 38 23 0 95
Total 2058 6129 1650 1251 11,088
% positively regulated by hlh-1 10% 6.1% 15% 0% 7.5%
% positively regulated by unc-120 40% 23% 30% 0% 25%
aGenes whose expression is significantly higher in muscle-enriched animals.
bGenes with similar expression levels with and without RNAi.
cGenes expressed less, though still present, in muscle-enriched animals.
dGenes not expressed in muscle-enriched animals.
Kuntz et al .
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explained by their known expression in pharynx or other tissues.
Among 2901 genes expressed preferentially in nonmuscle tissues
(Table 1), 1251 appeared entirely restricted to nonmuscle. The true
number of genes with this ‘‘nonmuscle’’ pattern is almost certainly
higher because our assay is not sensitive to genes expressed at low
levels in only a few cells, and there aremany such genes inC. elegans.
As expected, some classic BWM differentiation genes were
among the most strongly down-regulated by hlh-1 loss (Fig. 2D) or
unc-120 loss (Fig. 2E). RNA levels for these genes decreased signifi-
cantly (>one standard deviation), but none lost all detectable RNA
(seeDiscussion). At the other extreme, a different subgroup of BWM
genes, including tni-1 and major actins and myosins, were un-
affected by either hlh-1 or unc-120mutation (Supplemental Fig. S1;
Supplemental Table S2). Both unc-120 and hlh-1 contribute widely
to BWM and non-BWM exclusive genes (Fig. 2H). Overall, known
BWM genes displayed a broad range of quantitative responses to
hlh-1 and unc-120mutation, in both fractional and absolute change.
This suggests different regulatory strength contributions from them
and, implicitly, from additional transcription factors interacting
with subsets of target genes (Supplemental Fig. S1). Of 2058 genes
preferentially expressed in muscle, 10% (212) depended signifi-
cantly onhlh-1 for expression and40% (827) depended significantly
on unc-120 (Table 1). Of all hlh-1 positive regulatory targets, 212 are
muscle-preferred, 371 widespread, and 254 depleted but present in
BWM. Likewise, unc-120 positive regulatory targets are distributed
with 827 being muscle-preferred, 1390 widely expressed, and 501
being depleted but present in BWM.
hlh-1, but not unc-120, negatively regulates some NSM genes
An unexpected result was that NSM annotated genes were prom-
inent among the group of 307 genes up-regulated specifically in
the BWM-enriched hlh-1 mutant animals and not in wild-type
animals (Table 2). Prominent in this group was hlh-8, the central
regulator in the NSM differentiation network (Corsi et al. 2000),
and mls-1, another transcription factor in the NSM network
(Kostas and Fire 2002). These findings were unexpected since tri-
ple-RNAi treatment in wild-type embryos abolished, or at least
reduced, the entire NSM, including enteric muscles and the M cell
lineage. This suggests that a subnetwork of BWM genes behaves
differently than the rest of the tissue and that genes in this group
are candidate regulatory targets of hlh-8 and/or mls-1. Overall,
9.5% (195 genes) of the BWM preferred expression group were
annotated in WormBase as also expressed in normal NSM, and, of
these, 26 were up-regulated along with hlh-8 and mls-1. BWM/
NSM shared genes showed significant overlapwith hlh-1 positively
regulated target genes (hypergeometric P < 0.001). Ninety-five
percent of NSM genes, including hlh-8 and mls-1, were not
detectably elevated in unc-120 mutants, meaning it is likely that
repression of NSM circuitry is specific to hlh-1. Though unaffected
in BWM-enhanced wild-type embryos, hlh-8 was positively regu-
lated by unc-120 in muscle-normal animals, presumably by acting
in the NSM (which is absent in the BWM-enhanced condition).
Synthetic PAT screen for coregulators of hlh-1 and mediators
of hlh-8/hlh-1 crosstalk
As shown above, unc-120 partly explains the robustness of worm
myogenesis to hlh-1 mutation, but other factors might perform
a similar function for additional hlh-1 targets. To find other regu-
lators that collaborate with hlh-1, we performed a feeding RNAi
synthetic paralysis-at-twofold (Pat; WBPhenotype:0000053) phe-
notype analysis in the hlh-1(cc561) mutant background, using
a library of 512 genes that encode known and suspected tran-
scription factors. In nematodes, elongation of the embryo depends
on muscle contractions (Williams and Waterston 1994). The Pat
phenotype, therefore, serves as a readily scored surrogate for major
BWM failure. As expected, unc-120 scored strongly in this assay.
Other strong interactors included ceh-20, grh-1, tbp-1, lin-26, pos-1,
oma-2, nhr-4, nhr-46, nhr-63, nhr-116, hmg-1.2, hnd-1, and ceh-51
(Supplemental Table S5). The Pat phenotype suggests that each of
these contributes to expression of one or more genes needed for
differentiation of muscle in the absence of hlh-1.
A majority of these hlh-1 genetic interacting factors are
themselves regulated by hlh-1 and/or unc-120. TATA-binding pro-
tein (tbp-1) is part of the transcription initiation complex and is
positively regulated by both hlh-1 and unc-120, suggesting elevated
demand for it by some muscle differentiation genes. nhr-63 is
negatively regulated by hlh-1, while nhr-116 is negatively regulated
by unc-120. lin-26, pos-1, oma-2, nhr-4, and nhr-46 are positively
regulated by unc-120, suggesting feed-forward loops that are fa-
miliar structures in developmental circuits. nhr-63, grh-1, and ceh-
20 are normally expressed in NSM, so they are candidates for genes
that could interact with both hlh-1 and the hlh-8/mls-1 circuitry.
Genes positively regulated by hlh-1 and unc-120 are enriched
for HLH-1 occupancy, which is widespread
Tomap sites of HLH-1 occupancy in vivo,we performed chromatin
immunoprecipitation from RNAi fed wild-type embryos (both
mex-3 and triple RNAi) with an anti-HLH-1 antibody, followed by
DNA sequencing (ChIP-seq) (Johnson et al. 2007; Zhong et al.
2010). The most prominent signals were consistent in all condi-
tions (Supplemental Fig. S2), but BWM-enrichment was important
for detecting the majority of HLH-1 ChIP signals. We evaluated
ChIP-seq signal intensities and locations relative to background
Table 2. Genes up-regulated in the hlh-1 mutant muscle-
enhanced worms known to be expressed in wild-type NSM cells
Gene Description
B0336.3 RNA recognition
ags-3 G protein signaling
arr-1 beta-arrestin
C03H5.2 UDP transporter
ced-1 Lipoprotein receptor
cts-1 Citrate synthase
dpy-23 Adaptin
dsc-1 Defecation suppressor
egl-20 WNT, signaling protein
exp-1 GABA receptor
F47B7.2 Sulfhydryl oxidase
H28O16.1 ATP synthase
hlh-8 TWIST, transcription factor
mls-1 TBX1, transcription factor
mrp-2 Multidrug resistance protein
mua-6 Intermediate filament
mup-4 Muscle junctions
nlp-13 Neuropeptide
nmy-1 Nonmuscle myosin
ppk-3 PIP kinase
rom-1 Rhomboid related
shc-1 Signaling (src, jnk, insulin)
snb-1 Synaptic vesicle
trs-1 tRNA synthetase
uvt-3 Pantothenate kinase
ZK112.3 Unknown
hlh-1 and unc-120 network in worm myogenesis
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(Pepke et al. 2009) to produce a high confidence set of 1047 peaks
appearing in both RNAi conditions and a more inclusive union set
of 9415 peaks appearing in either RNAi condition (mex-3 RNAi
yielded 7021 peaks and triple RNAi yielded 3441 peaks; examples
in Fig. 3A,B). The peak yield was similar to that of Lei et al. (2010),
who recovered 20,143 peaks in their ChIP-seq experiment that
they narrowed to 4016 high-confidence peaks (Lei et al. 2010).
Their use of a different antibody likely accounts for much of the
difference in peak identification, though the overlap was statisti-
cally significant (P < 0.001). For their ChIP-chip analysis, they used
the same antibody but a different enrichment and detection
technique (Lei et al. 2010), leading to a similar sample size as our
high-confidence set of peaks and a statistically significant overlap
(P < 0.001). The muscle enrichment and regulatory dependence
of genes near peaks from both broad and stringent sets were
comparable, but the stringent group was more strongly
enriched. Thus, >50% and 20% of our hlh-1 positively regulated
gene list was captured in the broad and stringent HLH-1-bound
sets, respectively.
Eighty-nine percent of the stringent set of HLH-1-occupied
regions were within 5 kb 59-ward of an annotated gene start (in-
cluding regions that also fell within an upstream gene), with 36%
of those concentrated in the proximal 500 bp. Sixteen percent of
regions were in introns, 6.6% in exons, and only 1.2% in 39 UTRs
(Supplemental Table S3). The 5-kb 59-ward, 500-bp proximal, and
exon sequences were enriched genome-wide for HLH-1 ChIP peaks
(P < 0.01), while other regionswere depleted or not enriched (peaks
per kb).
Because hlh-1 is a highly cell-type-specific activating tran-
scription factor, an initial expectation was that most BWM-
specific genes would have one or more adjacent HLH-1 ChIP
regions. For specific CRMs and promoters previously shown to
drive BWM expression (Okkema et al. 1993; Krause et al. 1994),
this was true, with ChIP signals at expected locations (Supple-
mental Fig. S2). Genome-wide, 59.7% of the 941 annotated
BWM genes had HLH-1 occupancy (broad set) within the gene
body or 5 kb upstream (Supplemental Table S4), while 54% of
our BWM-enriched expression gene set did. Sixty-seven percent
of genes near a stringent HLH-1 peak
(i.e., within 5 kb of the start site) are
expressed at a significant level (RPKM > 3)
in BWM (P < 0.001). However, the vast
majority (80% in the stringent set and
87% in the broad set) were not muscle-
preferred in their expression pattern
(Fig. 3C; Discussion). Rather, the major-
ity are expressed widely in muscle and
nonmuscle tissue.
Genes whose expression depended
positively on hlh-1 (Table 1; dhp-2 in Fig.
3D) were significantly, but not strikingly,
enriched for HLH-1 occupancy within
5 kb upstream or in the gene body,
compared with other genes in the ge-
nome (57% vs. 49%, P < 0.001) (Supple-
mental Table S4), while negatively regu-
lated targets were not enriched (48% vs.
49%; hlh-8 in Fig. 3D). The overlap was
on par with that of Lei et al. (2010), with
our high-confidence peaks and their
ChIP-chip analysis both yielding 5% of
the occupied genes depending on hlh-1,
while their ChIP-seq analysis yielded 9%
of occupied genes depending on hlh-1 to
our 10% for our broader data set. Genes
depending on unc-120 (Table 1) were also
more likely to have HLH-1 occupancy
than the rest of the genome (53% vs.
49%, P < 0.001) (lin-25 in Fig. 3D). Genes
jointly up-regulated by both hlh-1 and
unc-120 function were similarly enriched
for HLH-1 occupancy (54% vs. 49%,
P < 0.002), though it is not required (skr-2
in Fig. 3D).
hlh-8, mls-1, and grl-26 were among
608 genes under negative regulation by
hlh-1 but not by direct binding, accord-
ing to the ChIP data (Fig. 3D). hlh-8, in
particular, had no HLH-1 binding in its
gene body nor within 20 kb upstream of
the TSS or 10 kb downstream.
Figure 3. HLH-1 ChIP-seq binding is associated with, but not predictive of, regulation. HLH-1 binds
to the genes (A) dhp-2 and (B) lin-25 (arrows). (C ) Venn diagram shows four criteria for rating in-
teractions of BWM preferred expression (red circle, 2175 genes), hlh-1 regulation of expression (blue
circle, 757 genes), HLH-1 ChIP-seq binding (green circle, 9519 genes), and the presence of a local HLH-1
binding motif (yellow circle, 3469 genes). The intersect of 78 genes is highlighted as the ‘‘Archetypal
Muscle List.’’ (D) Gene expression (RPKM levels from RNA-seq) levels illustrate different regulatory de-
pendency patterns for hlh-1 and unc-120, with (upper) or without (lower) detectable nearby HLH-1
occupancy. dhp-2 (gold frompanel C ) represents archetypalmuscle genes, positively regulated by hlh-1
with significant HLH-1 occupancy. lin-25 (green, from C ) is positively regulated by unc-120 but not
hlh-1, even though it has HLH-1 occupancy. skr-2 (blue, fromC ) is positively regulated by both hlh-1 and
unc-120. hlh-8 (black) represents a class up-regulated only in hlh-1 mutant BWM, suggesting indirect
negative regulation.
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ChIP-regions contain the canonical HLH-1 binding motif
and novel associated motifs
HLH-1-occupied regions were used to derive overrepresented se-
quence motifs. We expected to identify motifs responsible for di-
rect HLH-1 binding, together with possibly collaborating motifs,
since the latter are often present in functional cis-regulatory mod-
ules (Davidson 2007). Two substantially different motif discovery
algorithms found similar motifs (Methods). The primary motif was
AACAGCTG (Fig. 4A, first motif), which is an E-box family motif
(CANNTG is the known general motif for the bHLH family). The
core hexamer matches previous HLH-1 motif determinations from
yeast one-hybrid assays (Grove et al. 2009), in vivo ChIP-chip and
ChIP-seq (Lei et al. 2010), andmammalian MyoD (Cao et al. 2010),
while the adjacent AA produces a more specific site which is anal-
ogous, but not identical, to the most highly preferred myogenin
binding octa-E-box in mouse (CAGCTGRR) (Cao et al. 2010;
A Kirilusha and B Wold, in prep.). Six other motifs (Fig. 4A; Sup-
plemental Fig. S3) plus GA- and CT-simple repeat-rich regions
(Guhathakurta et al. 2002; GuhaThakurta et al. 2004) were found.
Expanding the search radius from 50 bp to 100 bp found a second
E-box: CAACTG (web logo not shown), reported previously as a
secondary site for HLH-1 binding (Grove et al. 2009; Lei et al. 2009).
Analyzed across all HLH-1 ChIP regions with a 250-bp radius,
the two E-boxes and the GAGACGCAGA motif (Fig. 4A, second
motif ), for which there is no known factor, were strongly centered
near ChIP-seq summits, with the most statistically significant cen-
tral concentration being in muscle-specific and unc-120 positively
regulated genes (P < 0.05; Fig. 4E; Supplemental Fig. S4). The cen-
tered position argues that a motif is partly or solely responsible for
the observed ChIP signal. Other motifs were more evenly distrib-
uted in the tested regions (Fig. 4B; Supplemental Fig. S3), consistent
with accessory or independent roles. As expected, the HLH-1 octa-
boxmotif wasmost highly overrepresented among genes expressed
preferentially in muscle (Fig. 4E).
HLH-1 ChIP-seq peaks near specific functional subsets of
genes were analyzed for motif discovery, position, and frequency.
Gene groups tested were those (1) strongly positively dependent
on hlh-1 for expression, (2) strongly negatively regulated by hlh-1,
(3) absent in bodywall muscle, (4) dependent on unc-120 for ex-
pression, (5) less stringently dependent on hlh-1 for expression,
and (6) dependent on both hlh-1 and unc-120. Motifs identified
above were rediscovered within some subsets, in addition to two
novel candidates: AAAANNNNNAAA and GCCGATTTGCCG (Fig.
4A, third motif; Supplemental Fig. S3, sixth motif). The GCCGAT
TTGCCG motif was specifically associated with genes that do not
positively dependon hlh-1 andwith genes that do dependon unc-120.
In fact, thismotifwas selectivelydepleted from thepositively regulated
HLH-1 gene set (P < 0.01).
HLH-1-bound regions are preferentially conserved
If HLH-1-occupied E-box motif instances located near hlh-1 regu-
lated genes are functionally significant, we expect them to be
preferentially conserved in evolution. Moreover, we expect func-
tional HLH-1 binding sites to be embedded in larger domains of
conservation that typify cis-regulatory modules. This was the case
around our set of HLH-1-occupied sites, with preferential conser-
vation among sequenced nematodes of 6200 bp (Fig. 4D). This
conservation was not restricted to sites near HLH-1 regulated
genes; rather, the larger set of HLH-1 ChIP regions located near
genes that were not regulated by hlh-1 or were not BWM-specific
displayed similar preferential conservation (Supplemental Fig.
S3B). This suggests that HLH-1 ChIP signals overall identify func-
tionally important sequences, but that these need not be adjacent
to muscle-specific or HLH-1-dependent genes. Among the new can-
didate motifs, three others show preferential conservation, while
GCCGATTTGCCG did not (Supplemental Fig. S3).
Discussion
Through analysis of the BWM differentiation network, we un-
covered a significant overlap in transcription factor function,
helping to explain the redundancy of the core factors, and a sur-
prising lack of muscle factor target specificity to BWM. This work
expanded loss-of-function analysis for BWM regulation to cover
the entire transcriptome, finding that 21% (4359) of C. elegans
genes are significantly affected by mutation of either hlh-1 or unc-
120. It was found that 3.7% (760) were affected by both regulators
(Table 1), and these were highly enriched for BWM annotation.
Their pattern of regulatory dependence helps to explain how and
why hlh-1 and unc-120 act as a synthetic lethal pair in the embryo.
However, an equally strong result was that 71%of jointly regulated
genes and 79% of HLH-1 or 69% of UNC-120 single targets are not
tissue-specific—rather, they are substantially regulated by the mus-
cle-specific factors in BWM and, presumably, by other unknown
regulators in nonmuscle tissues. By integrating our mapping of
regulatory connectivity with in vivo physical HLH-1 occupancy, we
were able to define a set of ‘‘archetypal’’ direct transcriptional targets
for hlh-1 (Fig. 3C and below); identify biologically pertinent indirect
regulatory relationships, including themajorNSM-specific regulator,
hlh-8 (Fig. 5A,B,C; below); and define a set of HLH-1 occupancy sites
located near broadly expressed genes. Since a significant number of
broadly expressedHLH-1-occupied lociwere functionally affectedby
hlh-1mutation (220 genes), we conclude that hlh-1 either originated
as a highly muscle-specific factor that has been drafted over time to
help regulate widely expressed target genes in the specific context of
muscle, or that hlh-1was originally a more general factor whose role
was narrowed to muscle tissue early in animal evolution. New hlh-1
collaborating factors expand the BWM differentiation regulatory
network and network orthology based on an RNAi screen formuscle
failure.
unc-120/hlh-1 compensation is based on overlapping roles
in regulatory target control
In nematodes, myogenesis is robust to mutation of either unc-120
or hlh-1 (Baugh and Hunter 2006; Fukushige et al. 2006); by con-
trast, the hlh-1 bHLH ortholog, myogenin, is absolutely required
for mammalian differentiation, and, in Drosophila, the unc-120
MADS family ortholog,Mef2 (also known asD-MEF2), is absolutely
required (Black and Olson 1998). Nevertheless, the common
theme is that bodywall or skeletal muscle differentiation in all
three phyla uses both bHLH andMADS regulators. Our results help
to explain the C. elegans network’s unique behavior in three ways.
First, 760 genes are jointly regulated (Table 1), and the regula-
tory contributions from the two factors are roughly additive rather
than highly synergistic. Significant residual expression (>30%) was
observed in each mutant strain for the vast majority of shared posi-
tively regulated targets (89%), and only one gene (tag-10) lost more
than 90%of its expression (Supplemental Fig. S1C). Though all these
numbers are sensitive to thresholds, the qualitative results remained
unchanged even when the stringency was significantly increased.
The troponin gene family, several of whose members have been
studied individually, nicely illustrates the varied regulatory specificity
hlh-1 and unc-120 network in worm myogenesis
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Figure 4. HLH-1-associated motifs correlate with directional expression control. (A) The web logo position-specific frequency matrix (PSFM) diagrams
for three representative motifs and the accompanying number of sites identified near HLH-1 occupancy (250-bp radius). (B) The relative locations of three
motifs compared to their experimentally identified binding sites (analyzed per Ozdemir et al. 2011). The AACAGCTGmotif is centered on the called ChIP-
seq peak (50%within625 bp of the peak for hlh-1 positively regulated or muscle-enriched genes). The GAGACGCAGAmotif (second panel) is less central
(within 75 bp). The GCCGatttGCCGmotif (third panel) shows no significant centrality. The gray line represents a uniform distribution. (C ) The occurrence
of eachmotif within6250 bp of the HLH-1 occupancy peak near genes (ChIP regions within 5 kb of a gene TSS) belonging to expression groups is shown.
The E-box shows the greatest enrichment for genes characterized as hlh-1 positively regulated (first panel). The GAGACGCAGA motif is more closely
associated with unc-120 positively regulated genes (second panel), whereas the GCCGatttGCCG motif is enriched near genes absent in BWM (third
panel). (D) The conservation across sequenced nematodes (elegans, briggsae, remanei, and brenneri ) of ChIP-seq identified regions with the threemotifs is
shown. Conservation around the in vivo binding (blue) and around themotif (red) is shown compared to background (light blue and pink) (Ozdemir et al.
2011), with higher values representing a higher level of conservation. The E-box and GAGACGCAGA motifs, along with their surrounding sequences, are
strongly conserved, while the GCCGatttGCCGmotif is not at all conserved. (E ) Heat maps show the level of motif enrichment (yellow) or depletion (blue)
for the CAgCTGtt, GAGACGCAGA, and GCCGatttGCCG motifs near broadly expressed genes that are similarly regulated (y-axis). The E-box is enriched
near genes positively regulated by hlh-1 and unc-120. The GAGACGCAGA motif is enriched near genes negatively regulated by hlh-1 and positively
regulated by unc-120. The GCCGatttGCCG motif is depleted near genes positively regulated by either factor. (F ) There are four classes of E-boxes
observed: Class I contains muscle E-boxes that are bound by HLH-1, and it is predicted thatmutation of these sites will lead to changes in expression, as the
nearby genes are both specific to BWM and regulated (positively or negatively, in contrast to the Archetypal Genes, which are exclusively positively
regulated) by hlh-1; Class II contains E-boxes that are similarly functional but are near genes not exclusively expressed in BWM; Class III contains E-boxes
that are not required for expression but likely make contributions to nearby genes that are expressed exclusively in BWM; and Class IV contains seemingly
nonfunctional E-boxes that are not required for expression or associated with BWM expression.
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across multiple muscle types as well as in nonmuscle tissue (Sup-
plemental Table S6). unc-120’s large pool of positive targets may be
partly explained by a broader activating role in both BWM and
NSM, rather than just onemuscle type,meaning that genes expressed
in bothmay be regulated primarily by unc-120. hlh-1’s smaller pool of
regulatory targets and proportionally larger role in repression may
reflect its narrow and specific function in BWMalone. This appears to
include the capacity to silence theNSMnetwork andpotentially other
nonmuscle gene networks.We cannot say yet how joint regulation is
encoded in the cis-regulatory DNA of most target genes, but the
specific list of HLH-1-occupied candidate CRMs belonging to jointly
regulated worm genes we produce (below) provides the field with
hundreds of specific starting points for direct tests via transgenic
assays.
Second, newly identified hlh-1 interacting DNA binding fac-
tors (CEH-20, NHR-63, GRH-1, HMG-1.2, and LIN-39) are strong
candidates to explain how important muscle genes, especially those
with no unc-120 response, can continue to be expressed without
hlh-1. Whether they act on many genes or only on small specific
subsets will now be testable by performing experiments like those
done above for hlh-1 and unc-120. Though the DNA binding motifs
for thesenewhlh-1 interactors are unknown tous, ourmotif discovery
analysis ofhlh-1-bound regionsproduced candidates for combinatoric
regulation. By several criteria, the most
impressive of these is GAGACGCAGA,
which is present in 1143 of 9447 HLH-
1-bound regions, is most highly enriched
in BWM-expressed genes, is preferentially
conserved, and is centrally concentrated
near HLH-1 ChIP-seq regions. The motif
is enriched near genes that are positively
regulated by unc-120 and negatively
regulated by hlh-1. Together, these facts
argue that it binds a significant collabo-
rating factor.
Third, hlh-8 and mls-1 were among
the genes strongly up-regulated in hlh-1
mutants, suggesting that a small and
specific subgroup of NSM muscle genes
contribute to what is otherwise BWM
myogenesis if hlh-1 is gone. Among hlh-1
interacting factors identified in the RNAi
screen, hmg-1.2 is also expressed nor-
mally in NSM and could function as part
of this intersecting circuit. Target genes
that are divergently regulated by unc-120
and hlh-1 might be explained as addi-
tional genes normally necessary in NSM
(a domain of unc-120 regulation) but not
in BWM.
Crosstalk between NSM and BWM
regulators without wholesale
tissue conversion
The finding that hlh-8 and mls-1 are
strongly up-regulated by hlh-1 mutation
raises several questions. At the tissue level,
does up-regulation of hlh-8 and mls-1 pro-
duce a wholesale transformation of BWM
into NSM? It appears not, since many
BWM-specific genes were readily detected
in hlh-1mutant RNA. Of 104 genes annotated as expressed in wild-
type BWM but not in NSM, all continued to be expressed signifi-
cantly in hlh-1 mutant embryos, with or without RNAi feeding. At
the network level, aremuscle genes normally expressed in bothNSM
and BWM similarly expressed in hlh-1 mutants, as would be ex-
pected if they are primarily positively regulated by unc-120, hlh-8,
and/or mls-1? Indeed, the vast majority (552 of 596) of genes an-
notated for both BWM and NSM expression in wild-type worms
were similarly expressed in hlh-1 mutants. Only four BWM/NSM
shared genes were reduced by more than two standard deviations
from their wild-type level in the mutant. However, hlh-8 up-regula-
tion is not sufficient to explainmuscle differentiation in the absence
of hlh-1, because it is not synthetic muscle-lethal with hlh-1.
At the level of circuit structure and molecular mechanism,
why and how is hlh-8 switched on in the absence of hlh-1, and
what does this imply about their relationship in normal muscle
development? Negative regulation of hlh-8 by hlh-1 is likely to
be by an indirect mechanism, partly because hlh-1 is known as
a positive regulator of its direct targets. In addition, we detected no
HLH-1 occupancy near hlh-8 or mls-1 via ChIP-seq, even at the
most relaxed peak calling stringency. Our RNA data show that
known positive regulators of hlh-8, such as unc-62, ceh-20, and
mab-5, are all present in both wild-type and hlh-1mutant animals,
Figure 5. hlh-1 negatively regulates the NSM transcription factor hlh-8. (A) Differential splicing of
different isoforms of egl-15 (a and b) is hlh-1-regulated in BWM. Splicing isoform b, specific to BWM, is
unaffected by the mutation, while isoform a, specific to NSM, is up-regulated specifically in the mutant
muscle. (B) HLH-1 binding sites local to the genes mab-5, unc-62, and sup-12 are shown, with arrows
representing the ChIP-seq peaks. Each gene contains an E-box motif characteristic of hlh-1 occupancy.
sup-12 is the only onewhose expression depends on hlh-1, but the other genesmay be regulated in part
by hlh-1. (C ) sup-12 depends on HLH-1 binding for expression (blue arrow). ThemRNA-binding protein
SUP-12 inhibits the splicing variant EGL-15a (Kuroyanagi et al. 2007). In the absence of hlh-1, grh-1 is
up-regulated and may be controlled (dashed line) by egl-15a (Zhong and Sternberg 2006) to regulate
mab-5 (Venkatesan et al. 2003). In turn, MAB-5 competes with LIN-39 to interact with CEH-20 and
UNC-62 in some cells to effect target expression or repression (Liu et al. 2006; Jiang et al. 2009; Potts
et al. 2009). They may act on hlh-8, which is known in some cells to depend on ceh-20 and mab-5
(Kenyon1986; Liu et al. 2006; Jiang et al. 2009). Therefore, in the absenceofhlh-1, sup-12decreases—leading
to an increase in egl-15a and grh-1. GRH-1 and EGL-15a work to activate the MAB-5/UNC-62/CEH-20
Hox/Pbx complex to up-regulate the normally repressed hlh-8. This pathway is supported by the ap-
pearance of grh-1, ceh-20, and lin-39 (shown in green) in the synthetic PAT screen as being integral for
muscle formation.
hlh-1 and unc-120 network in worm myogenesis
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making activation of hlh-8 highly plausible when negative regu-
lation mediated indirectly by hlh-1 is relieved (Harfe et al. 1998a).
Drawing on our data and additional studies, we propose
a specific model for regulation of hlh-8 by hlh-1 (Fig. 5). From the
synthetic PAT phenotype analysis, ceh-20, lin-39, and grh-1 were
identified as strong genetic hlh-1 interactors. By independent cri-
teria, each of these is also a candidate to help activate hlh-8. grh-1
positively regulatesmab-5 (Venkatesan et al. 2003), andmab-5/unc-
62/ceh-20 positively regulates hlh-8 in NSM (Liu and Fire 2000).
Furthermore, we found that egl-15a and grh-1 are up-regulated in
our hlh-1 mutants (Fig. 5A), and there is additional genetic pre-
cedent in Drosophila for interaction between mab-5 and egl-15
(Zhong and Sternberg 2006). EGL-15/FGFR is necessary for proper
sex myoblast (NSM) migration (Stern and Horvitz 1991). The pri-
mary splicing variant in NSM, EGL-15a, is down-regulated by SUP-
12, which destroys EGL-15a but not EGL-15b, the primary splicing
variant in BWM (Kuroyanagi et al. 2007). We found that the EGL-
15a RNA splice isoform is up-regulated in hlh-1 mutants. sup-12
expression depends on HLH-1 activity, and sup-12 has a high
confidence HLH-1 occupancy domain (Fig. 5B). We therefore
suggest that in normal BWM, HLH-1 drives SUP-12 to down-reg-
ulate EGL-15a and grh-1, while in hlh-1 mutant muscle, SUP-12 is
not expressed, and EGL-15a and grh-1 increase, thus activating
mab-5/unc-62/ceh-20 and leading to up-regulation of hlh-8 and
some of its NSM target genes (Fig. 5C). This should especially favor
target genes normally expressed in both NSM and BWM, since
collaborating factors from BWM are present.
There is also evidence for reciprocal repression of BWM by
NSM, since hlh-8mutants have an unstable and sometimes higher
number of BWM cells and their sex-specific muscles disappear
(Corsi et al. 2000, 2002). Up-regulation of hlh-8 in BWM in the
absence of hlh-1 is reminiscent of the connection reported in the
post-embryonic M lineage (Harfe et al. 1998a), and regulation of
normal M lineage development, which generates both NSM and
BWM, might account for the crosstalk we see in BWM upon hlh-1
mutation.
Defining ‘‘archetypal’’ hlh-1 target genes and their candidate
CRMs
We distilled a set of 78 genes and associated candidate cis-acting
regulatory modules that meet four criteria for being ‘‘archetypal’’
regulatory and molecular hlh-1 targets: (1) They are expressed
preferentially in BWM; (2) they display significantly reduced RNA
levels in hlh-1 mutants; (3) they have HLH-1 occupancy at one or
more sites in our ChIP-seq data; and (4) the HLH-1 occupancy re-
gion contains one or more instances of the extended myogenic
‘‘octa E-box’’ (AACAGCTG) (Supplemental Table S7; Fig. 3C). An
additional 154 genes satisfy criteria 2, 3, and 4 but are also strongly
expressed in tissues other than BWM. These genes apparently de-
pend on HLH-1 in the context of muscle and on other factors
elsewhere.
Membership in our list of candidate hlh-1 BWMCRMs did not
use DNA sequence conservation as an initial criterion, since re-
cently evolved active instances may exist and will be pertinent to
the network. This allowed us to ask if the candidate canonical
muscle CRM group is preferentially conserved, and it was. Prefer-
ential conservation encompassed a region of 6150 bp relative to
the HLH-1 ChIP peak (Fig. 4D), showing that this group of candi-
date CRMs has been under pressure to function. The muscle octa-
Ebox is evenmorehighly conserved than the surrounding domain,
suggesting that it drives binding of functional consequence.
The archetypal muscle HLH-1 targets were defined without
using unc-120 data, yet they are highly enriched in unc-120 regu-
latory targets. Thus, 56% of the hlh-1 archetypal loci are positively
regulated by unc-120, while only 18% of all genes are regulated by
unc-120. Similarly, 52% of genes satisfying criteria 2, 3, and 4 were
positive regulatory targets of unc-120. Finally, of the genes in the
archetypal group that are also unc-120-regulated, 20% contain an
85% match instance to GAGACGCAGA within their HLH-1-oc-
cupied region.
The archetypal HLH-1 target genes and candidate CRMs have
been defined by intentionally stringent multiple-measurement
intersection to help learn the defining and shared characteristics of
BWM regulation. It is, therefore, an underestimate of the BWM
group and highlights the important role hlh-1 plays in regulating
genes not specific to the BWM group.
HLH-1 occupancy versus hlh-1 regulatory impact
Expression of hlh-1 is specific to the bodywall muscle system, the
phenotype of hlh-1 null mutants is myogenic, and hlh-1 orthologs
across metazoan phyla regulate muscle development and differ-
entiation. This relative simplicity made it possible to address some
questions about factor occupancy that have been difficult in sys-
tems with larger genomes and more complex organization. First,
factor occupancy alone, as measured by HLH-1 ChIP-seq, is a per-
missive condition for regulating gene expression, but it is not
powerfully predictive of regulatory activity. In isolation, HLH-1
occupancy had low specificity for hlh-1-dependent RNA expres-
sion at nearby genes or TSS. HLH-1 occupancy in an independent
study (Lei et al. 2010) had almost identical specificity (9% in Lei
et al. [2010] versus 10% in this analysis). The Lei et al. (2010) study
also concluded thatmany siteswere upstreamof nonmuscle genes.
Their conclusion that binding was not predictive of enhancer ac-
tivity mirrors our conclusion that it is not predictive of regulatory
activity (Lei et al. 2010). Similarly, the majority of mouse MyoD
occupancy sites are located closest to nonmuscle-specific genes
(Cao et al. 2010). Substantial technical issues surrounding assay
sensitivity, combined with consequences from assigning binding
regions to genes by an overly simple proximity algorithm, are
probably responsible for some lack of predictive power. Never-
theless, the data are most consistent with a majority of detected
HLH-1 occupancy binding events having no regulatory effect or an
effect too small tomeasure.Where hlh-1 regulation is detected, the
majority of it is associatedwith genes that are not specific for BWM
alone.
From HLH-1 ChIP-seq regions, we refined the HLH-1 binding
motif preferentially affiliated with HLH-1-regulated loci (AACA
GCTG) and showed it is the dominant, centrally located driver for
HLH-1 genome occupancy. The distribution of additional novel
motifs from HLH-1-occupied regions, among the functionally dis-
tinct target gene groups, provided insights into BWM/NSM cis-
regulatory logic. TheGAGACGCAGAhas ahigh rate of co-occurrence
with the octa-Ebox and presence in HLH-1 ChIP regions. It is
a plausible candidate to bind UNC-120 or an intimate UNC-120
collaborator, as the motif is preferentially concentrated near genes
positively regulated by unc-120, significantly enriched in genes
annotated for NSM and BWM (Fig. 4E; Supplemental Fig. S4), and
present in more than half of archetypal BWM candidate CRMs.
Several other discovered motifs also colocalize with HLH-1 bind-
ing, but more weakly, and these are reasonable candidates to col-
laborate withHLH-1 in other target gene subgroups (Supplemental
Fig. S3). For example, CGnnGCGAGACCC is enriched near genes
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positively regulated by hlh-1 but negatively regulated by unc-120.
This pattern is expected for BWM genes that must be turned off in
NSM, a group with which it has significant overlap. In contrast,
GCCGatttGCCG is selectively depleted near genes positively reg-
ulated by either hlh-1 or unc-120, suggesting that this motif me-
diates a function that is orthogonal to muscle differentiation (Fig.
4E). None of the newly discovered motifs closely resemble known
transcription factor binding sites, although some bear resemblance
to previously reported muscle-associated motifs (Guhathakurta
et al. 2002; GuhaThakurta et al. 2004), and they are all candidates
to bind hlh-1 interacting factors from the RNAi screen.
Methods
Additional details may be found in the Supplemental Material.
General methods and strains
We obtained C. elegans strains N2, PD4605 (hlh-1(cc561)), and
RW364 (unc-120(st364)) from the Caenorhabditis Genetics Center
(CGC) and cultured them using standardmethods (Brenner 1974).
To increase the proportion of muscle, we chose to knock down
early specification genes (mex-3, elt-1, and skn-1) to permit muscle
specification (Fig. 1C; Supplemental Material).
RNAi feeding
Bacteria (Ahringer Lab RNAi Library) were used for control (HT115)
and mex-3 RNAi feeding, in addition to RNAi knockdown for the
synthetic PAT screen. The elt-1, mex-3 and skn-1 inserts were fused
in a single vector for triple RNAi feeding (Gouda et al. 2010).
Knocking down multiple RNA transcripts can suffer from poor
efficiency (Gonczy et al. 2000), but our concatenation technique
maintained high penetrance. Effectiveness was measured in ali-
quots from each biological replicate, with 100% of animals being
affected by RNAi (100% embryonic-lethal, with 0% making it to
the comma stage morphologically). Costaining with phalloidin
and DAPI revealed significant enrichment ofmyosin in N2worms,
though not every cell was converted to muscle. Synchronized
worms were grown on seeded NGM special plates with IPTG and
carboxy-penicillin at 15°C until the L4 stage, and then at 25°C
until gravid adults began egg-laying. Gravid adults were bleached,
and the eggs were shaken at 25°C in S-complete media (five
embryos/mL) for 400 min to ensure muscle differentiation but
avoid tissue necrosis (Fig. 1B).
ChIP-seq
Immunoprecipitation with an existing anti-HLH-1 polyclonal
antibody (Lei et al. 2009) was performed in N2 and hlh-1(cc561)
animalswith amodified protocol (Weinmann and Farnham2002).
While not a null, themutation effectively destroysHLH-1 function
(Lei et al. 2009), probably through non-sense mediated decay
(Harfe et al. 1998a), and no signal was seen above background.
Embryos were freeze-cracked in 2% formaldehyde on dry ice five
times, fixed for 30 min, and then quenched for 5 min. The em-
bryos were washed, lysed, and sonicated (Misonex, output 3.5)
with a microtip for 15 30-sec pulses with 1-min intervals. Ten
percent of the sample was set aside as control. The antibody was
added to the chromatin prep and allowed to mix for 16 h at 4°C.
Four sequential aliquots of 200 mL of magnetic beads (Invitrogen
Dynabeads M-280 Sheep anti-Rabbit IgG) were then added for 4 h
to extract the antibody. Beads were washed, the complexes eluted,
and theDNAorganically purified and quantified (InvitrogenQubit
Fluorometer). For ChIP sequencing, the average number of reads
was 176 2 million reads, the average number of unique reads was
12 6 1 million reads, and quality control failed on an average of
0.5 6 0.1 million reads (Supplemental Table S8).
RNA-seq
For RNA-based sequencing, embryos were flash-frozen in TRIzol
(Sigma) and freeze-cracked on dry ice five times. The embryos were
passed through a 21 G needle and a 25 G needle (103 each) to
shear the eggshell. The RNA was precipitated, treated with Turbo
DNase (Ambion), and dT-purified (Invitrogen Dynabeads Oligo-
dT). External quantification standardswere spiked in to themRNA,
which was then fragmented to an average length of 200 nt by
heating at 94°C in the presence of Mg++ for 90 sec. The fragmented
mRNA was then random-primed with hexamers for reverse tran-
scription first strand synthesis, followed bynick translation second
strand synthesis using a double-stranded cDNA synthesis kit
(Invitrogen). Comparisons were made between two biological
replicates that were independently sequenced for each condition,
except for untreated hlh-1mutants, for which only a single pooled
sample was sequenced. For RNA sequencing, the average number
of reads was 26 6 9 million reads, the average number of unique
reads was 20 6 7 million reads, and the average number of repeat
reads was 7 6 4 million reads (Supplemental Table S8). Quality
control failed on an average of 0.5 6 0.3 million reads per se-
quenced lane.
Library making and sequencing
The standard single amplification Illumina library-making protocol
was used, including end repair, adaptor ligation, gel purification,
and PCR amplification. Flowcell generation and sequencer running
followed the Illumina protocol. All sequencing data is publically
available. All genomic data are DNA-sequence-based and publicly
available through GEO (GSE28561, GSE28562, GSE28563).
RNAi feeding for synthetic lethal screening
Bacteria from the OpenBioSystems RNAi library and the Ahringer
RNAi library were used for RNAi feeding of L4 animals for 36 h at
25°C. Adults were then transferred to fresh plates for egg-laying for
4 h at 25°C. Adults were removed, and embryos were allowed to
develop for 18–24 h prior to scoring. Embryos were scored for de-
velopmental progression using a dissecting microscope. The stage
of developmental arrest in embryonic lethal worms was noted as
during the twofold stage (Pat) or otherwise.
Data analysis
WormBase release WS190 was used for all analysis. Read mapping
and read processing were performed with Bowtie and ERANGE
(Pepke et al. 2009). Python was used to perform calculations de-
scribed in the text. Genes associatedwith stress response (e.g., heat
shock genes) were monitored for signs of damage or stress. We
looked for enriched motifs near the ChIP-identified binding sites
using MEME on sequences within various radii of the binding site.
A greedy algorithm-based motif finder reproducibly identified the
major nonrepeat motifs found with MEME. Enrichments were
determined by x2 and hypergeometric statistical analysis.
Data access
All sequencing data have been submitted to the NCBI Gene Ex-
pression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) for
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‘‘HLH-1 binding in muscle-enriched embryos and RNA expression
in muscle-enriched embryos across different mutations’’ (accession
numberGSE28563, includingGSM707199–GSM707213), ‘‘Genome-
wide maps of HLH-1 binding in muscle-enriched embryos’’ (acces-
sion number GSE28561, including GSM707199–GSM707202), and
‘‘Genome-wide RNA expression in muscle-enriched embryos across
different mutations’’ (accession number GSE28562, including
GSM707203–GSM707213).
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